Cruzain

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 6: Line 6:
Cru inhibitors are being investigated for therapeutic use against Chagas disease.
Cru inhibitors are being investigated for therapeutic use against Chagas disease.
 +
 +
== Structural highlights ==
 +
 +
Cru catalytic triad is Cys-His-Asn.
</StructureSection>
</StructureSection>

Revision as of 11:30, 15 December 2015

Structure of cruzain catalytic domain complex with methylketone inhibitor (PDB entry 1me3)

Drag the structure with the mouse to rotate

3D structures of cruzain

Updated on 15-December-2015

1aim, 2aim, 1me3, 1me4 – Cru catalytic domain + methylketone inhibitor – Trypanosoma cruzi
1f29, 1f2a, 1f2b, 1f2c, 1ewo, 3lxs - Cru catalytic domain + vinyl sulfone derived inhibitor
1ewl, 1ewm – Cru catalytic domain + methylbutane inhibitor
1ewp - Cru catalytic domain + MOR-Leu-HPQ

References

  1. ↑ Brinen LS, Hansell E, Cheng J, Roush WR, McKerrow JH, Fletterick RJ. A target within the target: probing cruzain's P1' site to define structural determinants for the Chagas' disease protease. Structure. 2000 Aug 15;8(8):831-40. PMID:10997902

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky

Retrieved from "http://52.214.119.220/wiki/index.php/Cruzain"
Personal tools